Published August 1994
| Version v1
Journal article
FDG-PET for predicting the prognosis of malignant lymphoma
Creators
- 1. Narita Red Cross Hospital, Chiba (Japan)
Description
To evaluate the usefulness of FDG-PET as a predictor of prognosis, 34 patients with untreated malignant lymphoma in the head and neck region were studied. After FDG-PET and treatment, they were observed from 15 to 50 months. Tumors which were aggressive and resistant to treatment tended to show high uptake of FDG. The survival rate of patients with high uptake of FDG, DAR≥8, was lower than the rate of the other patients. It is considered to be useful to add FDG uptake of the tumor to other prognostic factors for predicting the prognosis. (author)
Additional details
Publishing Information
- Journal Title
- Annals of Nuclear Medicine
- Journal Volume
- 8
- Journal Issue
- 3
- Journal Page Range
- p. 187-191.
- ISSN
- 0914-7187
- CODEN
- ANMEEX
INIS
- Country of Publication
- Japan
- Country of Input or Organization
- Japan
- INIS RN
- 26008291
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- CHEMOTHERAPY; FLUORINE 18; FLUORODEOXYGLUCOSE; HEAD; LYMPHOMAS; NECK; POSITRON COMPUTED TOMOGRAPHY; RADIOTHERAPY; SURVIVAL CURVES; SURVIVAL TIME; UPTAKE
- Descriptors DEC
- ANTIMETABOLITES; BETA DECAY RADIOISOTOPES; BETA-PLUS DECAY RADIOISOTOPES; BODY; BODY AREAS; COMPUTERIZED TOMOGRAPHY; DISEASES; DRUGS; EMISSION COMPUTED TOMOGRAPHY; FLUORINE ISOTOPES; HOURS LIVING RADIOISOTOPES; IMMUNE SYSTEM DISEASES; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; LIGHT NUCLEI; MEDICINE; NANOSEC LIVING RADIOISOTOPES; NEOPLASMS; NUCLEI; ODD-ODD NUCLEI; RADIOISOTOPES; THERAPY; TOMOGRAPHY